LYVE1
Basic information
Region (hg38): 11:10556966-10611689
Previous symbols: [ "XLKD1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LYVE1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 23 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 2 | 0 |
Variants in LYVE1
This is a list of pathogenic ClinVar variants found in the LYVE1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-10559149-T-C | not specified | Uncertain significance (May 31, 2023) | ||
11-10559157-T-A | Uncertain significance (Feb 01, 2024) | |||
11-10559169-G-C | not specified | Uncertain significance (Jan 18, 2022) | ||
11-10559214-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
11-10559852-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
11-10559885-G-A | not specified | Uncertain significance (Apr 06, 2022) | ||
11-10560507-C-A | not specified | Uncertain significance (Mar 07, 2024) | ||
11-10560546-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
11-10560566-G-T | not specified | Uncertain significance (Nov 17, 2023) | ||
11-10560569-C-A | not specified | Uncertain significance (Feb 28, 2023) | ||
11-10560578-A-G | not specified | Likely benign (Jun 29, 2023) | ||
11-10560600-T-C | not specified | Uncertain significance (Oct 27, 2022) | ||
11-10560647-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
11-10563963-G-T | not specified | Uncertain significance (May 27, 2022) | ||
11-10563981-G-C | not specified | Uncertain significance (Sep 30, 2021) | ||
11-10564005-A-G | not specified | Uncertain significance (Nov 09, 2021) | ||
11-10564026-G-A | Likely benign (Mar 01, 2023) | |||
11-10564054-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
11-10564062-T-C | not specified | Uncertain significance (Mar 28, 2024) | ||
11-10564233-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
11-10564281-G-T | not specified | Uncertain significance (Sep 30, 2021) | ||
11-10564296-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
11-10564335-G-T | not specified | Uncertain significance (Mar 31, 2024) | ||
11-10564344-A-G | not specified | Uncertain significance (Jun 21, 2022) | ||
11-10568451-C-T | not specified | Uncertain significance (Nov 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LYVE1 | protein_coding | protein_coding | ENST00000256178 | 6 | 54724 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.72e-7 | 0.405 | 125699 | 0 | 48 | 125747 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.186 | 162 | 169 | 0.960 | 0.00000814 | 2097 |
Missense in Polyphen | 37 | 39.299 | 0.9415 | 523 | ||
Synonymous | -0.173 | 68 | 66.2 | 1.03 | 0.00000355 | 650 |
Loss of Function | 0.636 | 11 | 13.5 | 0.813 | 6.56e-7 | 167 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000517 | 0.000517 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000265 | 0.000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes. {ECO:0000269|PubMed:10037799}.;
- Pathway
- Hyaluronan uptake and degradation;Hyaluronan metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.175
Intolerance Scores
- loftool
- 0.830
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.96
Haploinsufficiency Scores
- pHI
- 0.450
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.212
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lyve1
- Phenotype
- immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- lyve1a
- Affected structure
- thoracic duct
- Phenotype tag
- abnormal
- Phenotype quality
- agenesis
Gene ontology
- Biological process
- cell-matrix adhesion;response to wounding;anatomical structure morphogenesis;hyaluronan catabolic process
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane;extracellular exosome
- Molecular function
- transmembrane signaling receptor activity;protein binding;hyaluronic acid binding;signaling receptor activity